CEBPB and metabolic dysfunction-associated steatotic liver disease: To further verify the expression of biomarkers, we used qRT‒PCR to compare the gene expression levels of CEBPD, H4C11, CEBPB, KLF4, and GATA3 in the peripheral blood of normal controls and NAFLD patients.